Literature DB >> 32037915

Grade 3A follicular lymphoma can be effectively controlled with very low-dose radiation therapy.

Brandon S Imber1, Karen Chau1, Eliana Goldberg1, Erel Joffe2, Joachim Yahalom1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32037915      PMCID： PMC7269818          DOI： 10.1080/10428194.2020.1716222

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  11 in total

1.  Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy.

Authors:  Zeina Ayoub; Therese Andraos; Sarah A Milgrom; Chelsea C Pinnix; Bouthaina S Dabaja; Sweet Ping Ng; Jillian R Gunther; Joseph D Khoury; Nathan H Fowler; Satva S Neelapu; Felipe Samaniego; Luis E Fayad; Loretta J Nastoupil
Journal:  Leuk Lymphoma       Date:  2019-04-03

Review 2.  Follicular lymphoma grade 3: review and updates.

Authors:  Gayatri Vaidyanathan; Myron S Czuczman
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-06-12

3.  Radiotherapy for indolent lymphomas: how much is enough?

Authors:  Lena Specht
Journal:  Lancet Oncol       Date:  2014-02-24       Impact factor: 41.316

4.  Low dose palliative radiotherapy for refractory aggressive lymphoma.

Authors:  Osamu Tanaka; Masahiko Oguchi; Takayoshi Iida; Senji Kasahara; Hideko Goto; Takeshi Takahashi
Journal:  Rep Pract Oncol Radiother       Date:  2016-08-24

5.  Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG.

Authors:  Jessica L Brady; Michael S Binkley; Carla Hajj; Monica Chelius; Karen Chau; Alex Balogh; Mario Levis; Andrea Riccardo Filippi; Michael Jones; Michael Mac Manus; Andrew Wirth; Masahiko Oguchi; Anders Krog Vistisen; Therese Youssef Andraos; Andrea K Ng; Berthe M P Aleman; Seo Hee Choi; Youlia Kirova; Sara Hardy; Gabriele Reinartz; Hans T Eich; Scott V Bratman; Louis S Constine; Chang-Ok Suh; Bouthaina Dabaja; Tarec C El-Galaly; David C Hodgson; Umberto Ricardi; Joachim Yahalom; Richard T Hoppe; N George Mikhaeel
Journal:  Blood       Date:  2018-11-16       Impact factor: 22.113

6.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

7.  Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients.

Authors:  R L M Haas; Ph Poortmans; D de Jong; M Verheij; M van der Hulst; J P de Boer; H Bartelink
Journal:  Eur J Cancer       Date:  2005-08       Impact factor: 9.162

8.  4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.

Authors:  Peter J Hoskin; Amy A Kirkwood; Bilyana Popova; Paul Smith; Martin Robinson; Eve Gallop-Evans; Stewart Coltart; Timothy Illidge; Krishnaswamy Madhavan; Caroline Brammer; Patricia Diez; Andrew Jack; Isabel Syndikus
Journal:  Lancet Oncol       Date:  2014-02-24       Impact factor: 41.316

9.  Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study.

Authors:  Vedang Murthy; Karen Thomas; Kerwyn Foo; David Cunningham; Bernadette Johnson; Andrew Norman; Alan Horwich
Journal:  Clin Lymphoma Myeloma       Date:  2008-08

Review 10.  Radiotherapy of follicular lymphoma: updated role and new rules.

Authors:  Joachim Yahalom
Journal:  Curr Treat Options Oncol       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.